Albendazole versus praziquantel for neurocysticercosis

Journal Article Albendazole versus praziquantel for neurocysticercosis Get access Shilpa S. Mehta, Shilpa S. Mehta Pharmacoeconomics Fellow Clinical Economics Research Unit, Georgetown University Medical Center, Washington, DC; when this was written she was a Pharm.D. student, College of Pharmacy, Rutgers University, Piscataway, NJ Search for other works by this author on: Oxford Academic Google Scholar Susan Hatfield, Susan Hatfield Clinical Coordinator Robert Wood Johnson University Hospital, New Brunswick, NJ Search for other works by this author on: Oxford Academic Google Scholar Lois Jessen, Lois Jessen Director Drug Information Services Search for other works by this author on: Oxford Academic Google Scholar David Vogel David Vogel Director of Pharmacy Robert Wood Johnson University Hospital, New Brunswick, NJ Search for other works by this author on: Oxford Academic Google Scholar American Journal of Health-System Pharmacy, Volume 55, Issue 6, 15 March 1998, Pages 598–600, https://doi.org/10.1093/ajhp/55.6.598 Published: 15 March 1998